NCT02824328View on ClinicalTrials.gov

A Pilot Study Investigating the Effect of Chemotherapy on the Tumoral Immunoprofile of Gynecologic Cancers

CompletedOBSERVATIONAL
Enrollment

47

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

July 25, 2019

Study Completion Date

January 10, 2022

Conditions
Ovarian CancerFallopian Tube CancerPeritoneal CancerUterine Endometrial Cancer
Trial Locations (1)

27710

Duke Cancer Institute, Durham

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Duke University

OTHER